Aggregation of Human Platelets by Acidic Mucopolysaccharide Extracted from Stichopus japonicus Selenka

Summary

The acidic mucopolysaccharide extracted from sea cucumber (Stichopus japonicus Selenka) (SJAMP) has been shown to cause platelets to aggregate. Using citrated platelet-rich plasma (PRP), washed platelets and formaldehyde-fixed platelets from humans, we investigated the effects of platelet inhibitors and various plasmas and their fractions on SJAMP-induced platelet aggregation. It was found that the lowest concentration of SJAMP required for the aggregation of human platelets was about 0.4 μg/ ml and the magnitude of aggregation induced by SJAMP was concentration dependent. The platelets were aggregated by SJAMP at 10 μg/ml in 25 out of 28 (89%) normal subjects tested. Platelet inhibitors such as PGE₁, aspirin, indomethacin, apyrase, antimycin, 2-deoxy-D-glucose and EDTA inhibited by 70 to 100% the aggregation induced by SJAMP. Washed platelets alone were not aggregated by SJAMP. In the presence of fibrinogetr, washed platelets were aggregated by SJAMP, but formaldehyde-fixed platelets were not. These data indicate that the SJAMP-induced human platelet aggregation requires extracellular calcium, fibrinogen, and energy metabolism. The second phase of aggregation is dependent upon the release of ADP, and cyclooxygenase pathway.

Keywords

Platelet aggregation - Acidic mucopolysaccharide - Humans

• References

• 1 Fan HZ, Chen JD, Lin KZ. An acidic mucopolysaccharide isolated from Stichopus japonicus Selenka and some of its physical and chemical properties. Yao Hseuh Hseuh Pao 1980; 15: 264-270
• 2 Li JZ, Bao CX, Chen GZ. Effect of acidic mucopolysaccharide extracted from Stichopus japonicus Selenka on hemostatic function. Chung Yao Tung Pao 1983; 8: 36-39
• 3 Li JZ, Bao CX, Chen JZ, Zhang GZ. Antithrombin activity and platelet aggregation by acid mucopolysaccharide isolated from Stichopus japonicus Selenka. Acta Pharmacol Sinica 1985; 6: 107-110
• 4 Wang H, Pan M, Huan X, Li S. Treatment of some thromboembolic disorders with SJAMP. Chin J Hematol 1985; 6: 596-698
• 5 Walsh PN, Mills DC B, White JG. Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol 1977; 36: 287-296
• 6 Macfarlane DE, Kirby EP, Zucker MB. A method for assaying von Willebrand factor (Ristocetin cofactor). Thromb Diathes Haemorrh 1975; 34: 306-307
• 7 Born GV R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
• 8 Brace LD, Fareed J. An objective assessment of interaction of heparin and its fractions with human platelets. Semin Thromb Hemostas 1985; 11: 190-198
• 9 Janson PA, Moake JL, Carpinito G. Aspirin prevents heparin-induced platelet aggregation. Br J Haematol 1983; 53: 166-168
• 10 Saba HI, Saba SR, Morelli GA. Effect of heparin on platelet aggregation. Am J Hematol 1984; 17: 295-306
• 11 Salzman EW, Rosenberg RD, Smith MH, Lindon JN. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980; 65: 64-73
• 12 Zucker MB. Heparin and platelet function. Fed Proc 1977; 36: 47-49
• 13 Eika C. Inhibition of thrombin-induced aggregation of human platelets by heparin. Scand J Haematol 1971; 8: 216-222
• 14 Eika C. The platelet aggregation effect of eight commercial heparins. Scand J Haematol 1972; 9: 480-482
• 15 Cofrancesco E, Colombi M, Cristoforetti G, Pogliani EM. Selective PF₄ release in vitro induced by heparin and related glycosaminoglycans (GAGs) - correlation with β-TG release and platelet aggregation. Thromb Haemostas 1984; 51: 105-107
• 16 Blockmans D, Bounameaux H, Vermylen J, Verstraete M. Heparin- induced thrombocytopenia. Platelet aggregation studies in the presence of heparin fractions or semi-synthetic analogues of various molecular weights and anticoagulant activities Thromb Haemostas 1986; 55: 90-93
• 17 McLean MR, Hause LL. The effect of bovine lung heparin on normal human platelets as measured by electronic particle size analysis. Thromb Haemostas 1982; 47: 5-7
• 18 Chong BH, Grace CS, Rozenberg MC. Heparin-induced thrombocytopenia: Effect of heparin platelet antibody on platelets. Br J Haematol 1981; 49: 531-540
• 19 Detwiler TC, Huang EM. Interactions of platelet activating pathways: Interrelationships of aggregation and secretion. In Platelet Responses and Metabolism. Holmsen H. (ed) CRC Press; Boca Raton, FL: 1986. 1 235-249
• 20 Regoeczi EFibrinogen. In Structure and Function of Plasma Proteins. Allison AC. (ed) Plenum Press; New York: 1974. 1 133-167
• 21 Ream VJ, Deykin D, Gurewich V, Wessler S. The aggregation of human platelets by bacterial endotoxin. J Lab Clin Med 1965; 66: 245-252
• 22 Johnson H, Nicklasson PM. Effect of meningococcal and Escherichia coli capsular polysaccharides on human and dog platelet aggregation in vitro. J Clin Pathol 1976; 29: 438-440
• 23 Nagayama M, Zucker MB, Beller FK. Effects of a variety of endotoxins on human and rabbit platelet function. Thromb Diathes Haemorrh 1971; 26: 467-473
• 24 MacIntyre DE, Allen AP, Thone KJ I, Glauert AM, Gordon JL. Endotoxin-induced platelet aggregation and secretion. I. Morphological changes and pharmacological effects. J Cell Sci 1977; 28: 211-223
• 25 Saba HJ, Saba SR, Morelli GT, Hartmann RC. Endotoxin-mediated inhibition of human platelet aggregation. Thromb Res 1984; 34: 19-33